Operating Expenses - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.2 PLN -0.18% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Operating Expenses Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Operating Expenses
-zł134.1m
CAGR 3-Years
-46%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Operating Expenses
-zł2.4m
CAGR 3-Years
6%
CAGR 5-Years
-14%
CAGR 10-Years
-3%
M
Medicofarma Biotech SA
WSE:MDB
Operating Expenses
-zł3m
CAGR 3-Years
-29%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Operating Expenses
-zł205.7m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Operating Expenses?
Operating Expenses
-134.1m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Operating Expenses amounts to -134.1m PLN.

What is Ryvu Therapeutics SA's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-54%

Over the last year, the Operating Expenses growth was -17%. The average annual Operating Expenses growth rates for Ryvu Therapeutics SA have been -46% over the past three years , -54% over the past five years .

Back to Top